Related Experiment Videos

Current treatment of hypertension. Part 2: Risk factors, drug treatment and economic aspects

J A Millar¹, H J Waal-Manning

¹Department of Pharmacology, University of Otago Medical School, Dunedin.

The New Zealand Medical Journal

|February 26, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Estimation of clinical and economic effects of prophylaxis against venous thromboembolism in medical patients, including the effect of targeting patients at high-risk.

Internal medicine journal·2016

A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.

British journal of clinical pharmacology·2015

Cerebral abscess following adenotonsillectomy: a rare complication.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2011

Selection of medical patients for prophylaxis of venous thromboembolism based on analysis of the benefit-hazard ratio.

Internal medicine journal·2009

Is the Australian HREC system unsustainable?

Monash bioethics review·2005

Relationship between sample size and the definition of equivalence in non-inferiority drug studies.

Journal of clinical pharmacy and therapeutics·2002

See all related articles